BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21677582)

  • 1. POEMS syndrome: the matter-of-fact approach.
    Scarlato M; Previtali SC
    Curr Opin Neurol; 2011 Oct; 24(5):491-6. PubMed ID: 21677582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
    He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
    Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
    Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
    Front Immunol; 2021; 12():681360. PubMed ID: 34025681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J; Nakashima M; Wong S
    JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
    Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
    BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.
    Scarlato M; Previtali SC; Carpo M; Pareyson D; Briani C; Del Bo R; Nobile-Orazio E; Quattrini A; Comi GP
    Brain; 2005 Aug; 128(Pt 8):1911-20. PubMed ID: 15975949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
    Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
    Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POEMS syndrome: A multisystem clonal disorder.
    Ali T; Qazilbash MH
    Eur J Haematol; 2021 Jan; 106(1):14-18. PubMed ID: 32889731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [POEMS syndrome: Diagnosis, stratification, treatments].
    Talbot A; Jaccard A; Arnulf B
    Rev Med Interne; 2021 May; 42(5):320-329. PubMed ID: 33678446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
    Arana C; Pérez de León JA; Gómez-Moreno G; Pérez-Cano R; Martín Hernández T
    Am J Case Rep; 2015 Mar; 16():124-9. PubMed ID: 25726020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Crow-Fukase syndrome and VEGF].
    Arimura K; Hashiguchi T; Watanabe O
    Brain Nerve; 2008 Jun; 60(6):611-9. PubMed ID: 18567356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An atypical presentation of POEMS syndrome with IgG kappa type M protein and normal VEGF level: Case report and review of literature.
    Pulivarthi S; Gurram MK
    J Cancer Res Ther; 2018; 14(3):679-681. PubMed ID: 29893339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
    Kanai K; Kuwabara S; Misawa S; Hattori T
    Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POEMS syndrome: clinical update.
    Brown R; Ginsberg L
    J Neurol; 2019 Jan; 266(1):268-277. PubMed ID: 30498913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
    Misawa S
    Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
    Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
    Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [POEMS syndrome: monoclonal plasma cell disorder with polyneuropathy].
    Kamezaki K; Nagafuji K
    Nihon Rinsho; 2007 Dec; 65(12):2235-7. PubMed ID: 18069266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New strategy of treatment for POEMS syndrome--autologous peripheral blood stem cell transplantation and thalidomide therapy].
    Kuwabara S
    Brain Nerve; 2008 Jun; 60(6):627-33. PubMed ID: 18567358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of serum vascular endothelial growth factors in wet beriberi: two case reports.
    Imai N; Kubota M; Saitou M; Yagi N; Serizawa M; Kobari M
    Intern Med; 2012; 51(8):929-32. PubMed ID: 22504253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
    Ordway S; Gilbert L; Wanko S
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.